HERALD is a Swedish collaborative research programme that includes several data sources linked together on patient level. Data sources include registers with national coverage, regional data with labs, BMI, and liver ultrasound, as well as quality register data from the national diabetes register. HERALD will be able to study important aspects of epidemiology, treatment patterns, and burden of disease on a national level (10M inh.) as well as perform more in-depth analysis using non-invasive risk scores and liver ultrasound in the Stockholm region (2M inh.).
HERALD is planned to generate quality research in the field of CLD between 2021-2026. Research data sets are planned to be amended with additional relevant variables during the course of the research programme.